BioMS Medical Corp (TSX: MS), a leading
developer in the treatment of multiple sclerosis (MS), today announced that
effective March 24, 2006, its Board of Directors had appointed
PricewaterhouseCoopers LLP, Chartered Accountants ("Pricewaterhouse") as the
Company's new independent auditors, replacing the firm of Collins Barrow,
Chartered Accountants ("Collins Barrow").
